Ryerson (RYI) Financials

$20.99 -0.08 (-0.38%)

Closing price 05/29/2025 03:59 PM Eastern

Extended Trading

$21.01 +0.02 (+0.10%)

As of 05/29/2025 04:04 PM Eastern

Annual Income Statements for Ryerson

This table shows Ryerson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-8.60	146	391
Consolidated Net Income / (Loss)	-7.30	146	392
Net Income / (Loss) Continuing Operations	-7.30	146	392
Total Pre-Tax Income	-7.40	194	523
Total Operating Income	32	228	579
Total Gross Profit	834	1,022	1,310
Total Revenue	4,599	5,109	6,324
Operating Revenue	4,599	5,109	6,324
Total Cost of Revenue	3,765	4,087	5,014
Operating Cost of Revenue	3,765	4,087	5,014
Total Operating Expenses	803	794	731
Selling, General & Admin Expense	801	794	735
Restructuring Charge	3.10	0.00	0.00
Other Special Charges / (Income)	-1.60	0.00	-3.80
Total Other Income / (Expense), net	-39	-34	-56
Interest Expense	43	35	55
Other Income / (Expense), net	4.10	0.30	-1.30
Income Tax Expense	-0.10	47	131
Net Income / (Loss) Attributable to Noncontrolling Interest	1.30	0.70	0.50
Basic Earnings per Share	($0.26)	$4.17	$10.41
Weighted Average Basic Shares Outstanding	31.85M	34.02M	36.99M
Diluted Earnings per Share	($0.26)	$4.10	$10.21
Weighted Average Diluted Shares Outstanding	31.85M	34.02M	36.99M
Weighted Average Basic & Diluted Shares Outstanding	31.85M	34.02M	36.99M
Cash Dividends to Common per Share	$0.75	$0.72	$0.54

This table shows Ryerson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-4.30	-6.60	9.90	-7.60	26	35	38	47	-24	55
Consolidated Net Income / (Loss)	-4.20	-6.00	10	-7.40	26	35	38	48	-24	55
Net Income / (Loss) Continuing Operations	-4.20	-6.00	10	-7.40	26	35	38	48	-24	55
Total Pre-Tax Income	-4.80	-6.40	13	-9.50	34	48	50	62	-35	76
Total Operating Income	2.60	5.30	23	0.80	44	56	58	70	-27	85
Total Gross Profit	191	202	224	218	247	249	261	264	163	271
Total Revenue	1,007	1,127	1,226	1,239	1,112	1,247	1,344	1,406	1,288	1,543
Operating Revenue	1,007	1,127	1,226	1,239	1,112	1,247	1,344	1,406	1,288	1,543
Total Cost of Revenue	816	925	1,002	1,022	865	997	1,083	1,142	1,125	1,272
Operating Cost of Revenue	816	925	1,002	1,022	865	997	1,083	1,142	1,125	1,272
Total Operating Expenses	189	197	201	217	204	193	203	194	191	187
Selling, General & Admin Expense	189	197	199	217	204	193	203	194	191	187
Total Other Income / (Expense), net	-7.40	-12	-9.50	-10	-10	-8.10	-8.60	-7.70	-7.30	-8.90
Interest Expense	10	12	11	10	9.50	9.30	8.30	7.60	27	9.10
Other Income / (Expense), net	2.70	-0.20	1.80	-0.20	-0.50	1.20	-0.30	-0.10	20	0.20
Income Tax Expense	-0.60	-0.40	3.00	-2.10	7.50	13	12	15	-11	21
Net Income / (Loss) Attributable to Noncontrolling Interest	0.10	0.60	0.40	0.20	0.20	0.30	0.00	0.20	0.30	0.00
Basic Earnings per Share	($0.13)	($0.20)	$0.29	($0.22)	$0.78	$1.02	$1.07	$1.30	($0.54)	$1.49
Weighted Average Basic Shares Outstanding	31.85M	31.85M	33.20M	34.34M	34.02M	34.17M	34.39M	35.77M	36.99M	37.01M
Diluted Earnings per Share	($0.13)	($0.20)	$0.29	($0.22)	$0.77	$1.00	$1.06	$1.27	($0.52)	$1.46
Weighted Average Diluted Shares Outstanding	31.85M	31.85M	33.20M	34.34M	34.02M	34.17M	34.39M	35.77M	36.99M	37.01M
Weighted Average Basic & Diluted Shares Outstanding	31.85M	31.85M	33.20M	34.34M	34.02M	34.17M	34.39M	35.77M	36.99M	37.01M
Cash Dividends to Common per Share	$0.19	$0.19	$0.19	$0.19	$0.19	$0.18	$0.18	$0.17	$0.16	$0.15

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-26	15	-12
Net Cash From Operating Activities	205	365	501
Net Cash From Continuing Operating Activities	205	365	501
Net Income / (Loss) Continuing Operations	-7.30	146	392
Consolidated Net Income / (Loss)	-7.30	146	392
Depreciation Expense	78	63	59
Non-Cash Adjustments To Reconcile Net Income	24	17	7.70
Changes in Operating Assets and Liabilities, net	111	139	43
Net Cash From Investing Activities	-143	-262	-160
Net Cash From Continuing Investing Activities	-143	-262	-160
Purchase of Property, Plant & Equipment	-100	-122	-105
Acquisitions	-44	-138	-57
Purchase of Investments	0.00	0.00	-2.00
Sale of Property, Plant & Equipment	2.10	0.50	8.00
Other Investing Activities, net	-1.10	-2.90	-3.90
Net Cash From Financing Activities	-87	-88	-350
Net Cash From Continuing Financing Activities	-87	-88	-350
Repayment of Debt	-8.60	-8.80	-333
Repurchase of Common Equity	-51	-114	-50
Payment of Dividends	-25	-25	-20
Issuance of Debt	32	70	26
Other Financing Activities, net	-34	-11	27
Effect of Exchange Rate Changes	-1.50	0.20	-3.00
Cash Interest Paid	41	30	38
Cash Income Taxes Paid	10	6.20	177

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-7.50	7.60	-14	-12	17	7.40	-14	4.50	-12	9.50
Net Cash From Operating Activities	92	135	26	-48	90	79	115	80	182	152
Net Cash From Continuing Operating Activities	92	135	26	-48	90	79	115	80	182	152
Net Income / (Loss) Continuing Operations	-4.20	-6.00	10	-7.40	26	35	38	48	-24	55
Consolidated Net Income / (Loss)	-4.20	-6.00	10	-7.40	26	35	38	48	-24	55
Depreciation Expense	23	20	18	17	20	14	15	14	17	15
Non-Cash Adjustments To Reconcile Net Income	11	4.00	2.50	6.30	13	2.00	4.00	-2.30	1.40	1.10
Changes in Operating Assets and Liabilities, net	63	117	-4.90	-64	31	28	59	22	188	81
Net Cash From Investing Activities	-24	-75	-23	-20	-115	-23	-58	-67	-69	-47
Net Cash From Continuing Investing Activities	-24	-75	-23	-20	-115	-23	-58	-67	-69	-47
Purchase of Property, Plant & Equipment	-24	-32	-23	-22	-25	-22	-46	-28	-34	-28
Sale of Property, Plant & Equipment	0.20	0.40	0.10	1.40	0.40	-	0.10	0.00	-	0.80
Other Investing Activities, net	-0.60	-0.10	-	0.00	-2.70	-0.20	-	-	-3.90	-
Net Cash From Financing Activities	-75	-52	-17	56	41	-49	-70	-9.90	-125	-89
Net Cash From Continuing Financing Activities	-75	-52	-17	56	41	-49	-70	-9.90	-125	-89
Repayment of Debt	-1.30	-1.50	-3.80	-2.00	-2.40	-2.10	-2.40	-1.90	-139	82
Payment of Dividends	-6.00	-6.00	-6.40	-6.40	-6.30	-6.30	-6.20	-6.00	-5.90	-5.50
Issuance of Debt	-55	-3.60	29	61	71	-30	1.00	28	-	-
Other Financing Activities, net	-12	-4.90	-22	4.60	-15	-6.80	-12	23	-5.40	-22
Effect of Exchange Rate Changes	-1.30	0.40	-0.20	-0.40	1.20	-	-1.70	0.70	0.70	-5.40
Cash Interest Paid	8.40	12	9.60	11	9.20	7.80	6.80	6.10	7.30	6.30
Cash Income Taxes Paid	1.80	1.00	1.10	6.40	-0.40	1.30	3.30	2.00	17	32

This table presents Ryerson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	2,440	2,570	2,334
Total Current Assets	1,208	1,383	1,442
Cash & Equivalents	28	54	39
Restricted Cash	1.60	1.10	1.30
Accounts Receivable	426	468	514
Inventories, net	685	783	799
Prepaid Expenses	68	78	88
Plant, Property, & Equipment, net	637	590	458
Plant, Property & Equipment, gross	1,152	-	-
Accumulated Depreciation	515	-	-
Total Noncurrent Assets	595	597	434
Goodwill	162	158	129
Intangible Assets	68	74	51
Other Noncurrent Operating Assets	365	365	254
Total Liabilities & Shareholders' Equity	2,440	2,570	2,334
Total Liabilities	1,615	1,655	1,441
Total Current Liabilities	580	634	619
Short-Term Debt	0.70	8.20	5.80
Accounts Payable	441	463	438
Accrued Expenses	103	128	145
Current Employee Benefit Liabilities	3.70	4.00	4.80
Other Current Liabilities	32	31	25
Total Noncurrent Liabilities	1,035	1,021	822
Long-Term Debt	467	428	361
Noncurrent Deferred & Payable Income Tax Liabilities	129	136	114
Noncurrent Employee Benefit Liabilities	91	107	118
Other Noncurrent Operating Liabilities	348	351	229
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	825	915	893
Total Preferred & Common Equity	815	906	885
Preferred Stock	0.00	0.00	0.00
Total Common Equity	815	906	885
Common Stock	424	412	398
Retained Earnings	780	813	693
Treasury Stock	-234	-179	-61
Accumulated Other Comprehensive Income / (Loss)	-154	-140	-144
Noncontrolling Interest	9.20	8.60	7.90

This table presents Ryerson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,533	2,591	2,720	2,434	2,522	2,402	2,547
Total Current Assets	1,301	1,389	1,525	1,359	1,448	1,457	1,701
Cash & Equivalents	35	28	42	37	30	44	51
Restricted Cash	1.80	1.20	1.10	1.10	1.10	1.30	1.20
Accounts Receivable	500	529	549	545	581	615	646
Inventories, net	681	744	841	699	754	711	933
Prepaid Expenses	84	87	93	76	83	85	70
Plant, Property, & Equipment, net	635	603	595	544	532	486	428
Plant, Property & Equipment, gross	1,135	1,099	1,081	1,011	994	938	854
Accumulated Depreciation	500	495	487	467	462	452	426
Total Noncurrent Assets	597	599	600	532	542	459	418
Goodwill	160	161	161	136	136	135	125
Intangible Assets	71	69	71	60	63	64	41
Other Noncurrent Operating Assets	366	369	368	335	343	259	252
Total Liabilities & Shareholders' Equity	2,533	2,591	2,720	2,434	2,522	2,402	2,547
Total Liabilities	1,691	1,705	1,823	1,543	1,655	1,521	1,655
Total Current Liabilities	585	583	729	634	712	665	705
Short-Term Debt	1.80	1.40	3.70	5.90	3.50	4.00	9.60
Accounts Payable	444	439	580	478	557	522	511
Accrued Expenses	104	69	111	72	73	71	92
Current Employee Benefit Liabilities	4.00	43	4.00	49	49	42	68
Other Current Liabilities	32	30	30	29	29	26	25
Total Noncurrent Liabilities	1,106	1,122	1,094	910	943	855	950
Long-Term Debt	520	524	494	360	393	391	467
Noncurrent Deferred & Payable Income Tax Liabilities	136	139	141	131	125	119	99
Noncurrent Employee Benefit Liabilities	97	103	106	111	112	112	153
Other Noncurrent Operating Liabilities	353	356	354	308	314	233	231
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	842	886	897	891	866	881	893
Total Preferred & Common Equity	833	878	889	883	858	873	885
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	833	878	889	883	858	873	885
Common Stock	423	420	416	408	404	401	396
Retained Earnings	790	803	799	794	765	734	723
Treasury Stock	-234	-198	-184	-173	-169	-118	-60
Accumulated Other Comprehensive Income / (Loss)	-146	-146	-142	-146	-142	-144	-173
Noncontrolling Interest	9.10	8.50	8.70	8.30	8.10	8.00	7.60

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-9.98%	-19.21%	11.42%
EBITDA Growth	-61.09%	-54.29%	6.03%
EBIT Growth	-84.41%	-60.44%	6.08%
NOPAT Growth	-87.21%	-60.21%	4.68%
Net Income Growth	-104.99%	-62.61%	32.53%
EPS Growth	-106.34%	-59.84%	35.05%
Operating Cash Flow Growth	-43.88%	-27.15%	1,332.00%
Free Cash Flow Firm Growth	-42.83%	-72.11%	74.37%
Invested Capital Growth	-2.55%	6.24%	7.78%
Revenue Q/Q Growth	-2.23%	-3.33%	-3.74%
EBITDA Q/Q Growth	-23.67%	35.24%	-28.94%
EBIT Q/Q Growth	-51.43%	46.22%	-31.07%
NOPAT Q/Q Growth	-58.90%	42.48%	-23.44%
Net Income Q/Q Growth	-131.88%	51.55%	-24.97%
EPS Q/Q Growth	-140.63%	45.91%	-24.09%
Operating Cash Flow Q/Q Growth	1.04%	-20.04%	17.54%
Free Cash Flow Firm Q/Q Growth	199.83%	-56.21%	11.95%
Invested Capital Q/Q Growth	-4.87%	6.33%	-7.43%
Profitability Metrics	-	-	-
Gross Margin	18.14%	20.00%	20.72%
EBITDA Margin	2.46%	5.69%	10.06%
Operating Margin	0.69%	4.46%	9.15%
EBIT Margin	0.77%	4.47%	9.13%
Profit (Net Income) Margin	-0.16%	2.87%	6.19%
Tax Burden Percent	98.65%	75.58%	74.87%
Interest Burden Percent	-20.79%	84.81%	90.56%
Effective Tax Rate	0.00%	24.42%	25.13%
Return on Invested Capital (ROIC)	1.72%	13.71%	36.86%
ROIC Less NNEP Spread (ROIC-NNEP)	-5.44%	6.36%	27.71%
Return on Net Nonoperating Assets (RNNOA)	-2.56%	2.49%	17.61%
Return on Equity (ROE)	-0.84%	16.20%	54.47%
Cash Return on Invested Capital (CROIC)	4.30%	7.66%	29.37%
Operating Return on Assets (OROA)	1.42%	9.32%	24.57%
Return on Assets (ROA)	-0.29%	5.97%	16.66%
Return on Common Equity (ROCE)	-0.83%	16.05%	53.89%
Return on Equity Simple (ROE_SIMPLE)	-0.90%	16.16%	44.23%
Net Operating Profit after Tax (NOPAT)	22	172	433
NOPAT Margin	0.48%	3.37%	6.85%
Net Nonoperating Expense Percent (NNEP)	7.17%	7.35%	9.15%
Return On Investment Capital (ROIC_SIMPLE)	1.71%	12.76%	34.39%
Cost of Revenue to Revenue	81.86%	80.00%	79.28%
SG&A Expenses to Revenue	17.42%	15.53%	11.63%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	17.45%	15.53%	11.57%
Earnings before Interest and Taxes (EBIT)	36	228	577
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	113	291	636
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.72	1.27	1.20
Price to Tangible Book Value (P/TBV)	1.01	1.70	1.50
Price to Revenue (P/Rev)	0.13	0.22	0.17
Price to Earnings (P/E)	0.00	7.87	2.71
Dividend Yield	4.05%	2.14%	1.87%
Earnings Yield	0.00%	12.70%	36.86%
Enterprise Value to Invested Capital (EV/IC)	0.82	1.19	1.14
Enterprise Value to Revenue (EV/Rev)	0.23	0.30	0.22
Enterprise Value to EBITDA (EV/EBITDA)	9.16	5.28	2.19
Enterprise Value to EBIT (EV/EBIT)	29.12	6.73	2.42
Enterprise Value to NOPAT (EV/NOPAT)	47.02	8.92	3.22
Enterprise Value to Operating Cash Flow (EV/OCF)	5.06	4.21	2.78
Enterprise Value to Free Cash Flow (EV/FCFF)	18.83	15.96	4.04
Leverage & Solvency	-	-	-
Debt to Equity	0.57	0.48	0.41
Long-Term Debt to Equity	0.57	0.47	0.40
Financial Leverage	0.47	0.39	0.64
Leverage Ratio	2.88	2.71	3.27
Compound Leverage Factor	-0.60	2.30	2.96
Debt to Total Capital	36.18%	32.31%	29.13%
Short-Term Debt to Total Capital	0.05%	0.61%	0.46%
Long-Term Debt to Total Capital	36.13%	31.70%	28.67%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.71%	0.64%	0.63%
Common Equity to Total Capital	63.11%	67.05%	70.25%
Debt to EBITDA	4.13	1.50	0.58
Net Debt to EBITDA	3.87	1.31	0.51
Long-Term Debt to EBITDA	4.12	1.47	0.57
Debt to NOPAT	21.20	2.53	0.85
Net Debt to NOPAT	19.87	2.21	0.75
Long-Term Debt to NOPAT	21.17	2.48	0.83
Altman Z-Score	2.91	3.49	4.81
Noncontrolling Interest Sharing Ratio	1.02%	0.91%	1.06%
Liquidity Ratios	-	-	-
Current Ratio	2.08	2.18	2.33
Quick Ratio	0.78	0.82	0.89
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	55	96	345
Operating Cash Flow to CapEx	210.15%	300.74%	516.17%
Free Cash Flow to Firm to Interest Expense	1.28	2.78	6.34
Operating Cash Flow to Interest Expense	4.77	10.52	9.20
Operating Cash Flow Less CapEx to Interest Expense	2.50	7.02	7.41
Efficiency Ratios	-	-	-
Asset Turnover	1.84	2.08	2.69
Accounts Receivable Turnover	10.30	10.40	11.04
Inventory Turnover	5.13	5.17	6.15
Fixed Asset Turnover	7.50	9.75	14.94
Accounts Payable Turnover	8.33	9.06	10.90
Days Sales Outstanding (DSO)	35.45	35.08	33.05
Days Inventory Outstanding (DIO)	71.12	70.60	59.36
Days Payable Outstanding (DPO)	43.83	40.27	33.48
Cash Conversion Cycle (CCC)	62.74	65.41	58.93
Capital & Investment Metrics	-	-	-
Invested Capital	1,263	1,296	1,220
Invested Capital Turnover	3.60	4.06	5.38
Increase / (Decrease) in Invested Capital	-33	76	88
Enterprise Value (EV)	1,037	1,537	1,395
Market Capitalization	589	1,147	1,061
Book Value per Share	$25.60	$26.51	$23.91
Tangible Book Value per Share	$18.38	$19.74	$19.05
Total Capital	1,292	1,351	1,260
Total Debt	467	437	367
Total Long-Term Debt	467	428	361
Net Debt	438	381	327
Capital Expenditures (CapEx)	98	121	97
Debt-free, Cash-free Net Working Capital (DFCFNWC)	599	702	788
Debt-free Net Working Capital (DFNWC)	628	758	828
Net Working Capital (NWC)	628	750	822
Net Nonoperating Expense (NNE)	29	26	42
Net Nonoperating Obligations (NNO)	438	381	327
Total Depreciation and Amortization (D&A)	78	63	59
Debt-free, Cash-free Net Working Capital to Revenue	13.02%	13.75%	12.46%
Debt-free Net Working Capital to Revenue	13.66%	14.83%	13.10%
Net Working Capital to Revenue	13.65%	14.67%	13.01%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.26)	$4.17	$10.41
Adjusted Weighted Average Basic Shares Outstanding	31.85M	34.02M	36.99M
Adjusted Diluted Earnings per Share	($0.26)	$4.10	$10.21
Adjusted Weighted Average Diluted Shares Outstanding	31.85M	34.02M	36.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.85M	34.02M	36.99M
Normalized Net Operating Profit after Tax (NOPAT)	23	172	430
Normalized NOPAT Margin	0.50%	3.37%	6.81%
Pre Tax Income Margin	-0.16%	3.79%	8.27%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.83	6.58	10.59
NOPAT to Interest Expense	0.51	4.97	7.95
EBIT Less CapEx to Interest Expense	-1.44	3.08	8.81
NOPAT Less CapEx to Interest Expense	-1.75	1.47	6.17
Payout Ratios	-	-	-
Dividend Payout Ratio	-339.73%	16.94%	5.08%
Augmented Payout Ratio	-1,038.36%	94.74%	17.85%

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.44%	-9.63%	-8.78%	-11.87%	-13.65%	-19.21%	-22.94%	-19.60%	-16.02%	-2.03%
EBITDA Growth	-55.63%	-65.40%	-41.72%	-78.47%	633.72%	-28.33%	-74.44%	-65.54%	-96.79%	5.98%
EBIT Growth	-87.67%	-91.13%	-57.59%	-99.14%	644.30%	-32.11%	-78.64%	-69.49%	-103.13%	6.14%
NOPAT Growth	-94.61%	-91.00%	-59.97%	-98.95%	276.02%	-33.05%	-79.39%	-69.64%	-116.76%	-55.85%
Net Income Growth	-116.15%	-117.00%	-72.61%	-115.58%	209.24%	-35.93%	-80.86%	-71.00%	-122.35%	10.20%
EPS Growth	-116.88%	-120.00%	-72.64%	-117.32%	248.08%	-31.51%	-79.22%	-69.54%	-119.12%	14.96%
Operating Cash Flow Growth	2.33%	69.74%	-77.54%	-159.45%	-50.39%	-47.69%	34.85%	-2.55%	70.04%	832.37%
Free Cash Flow Firm Growth	182.24%	-174.99%	-186.66%	-460.20%	60.50%	171.53%	156.62%	120.35%	-5.65%	-100.70%
Invested Capital Growth	-2.55%	8.93%	12.28%	9.78%	6.24%	-7.51%	-8.20%	1.66%	7.78%	24.29%
Revenue Q/Q Growth	-10.58%	-8.07%	-1.11%	11.40%	-10.77%	-7.21%	-4.45%	9.15%	-16.52%	-11.49%
EBITDA Q/Q Growth	13.82%	-42.25%	136.67%	-71.47%	-11.25%	-2.74%	-12.56%	758.27%	-91.33%	-65.31%
EBIT Q/Q Growth	3.92%	-79.27%	4,000.00%	-98.60%	-25.22%	-0.86%	-17.02%	339.38%	-109.33%	-68.80%
NOPAT Q/Q Growth	-50.94%	-78.99%	3,053.06%	-98.34%	-18.12%	-6.52%	-17.36%	378.26%	-131.14%	-71.22%
Net Income Q/Q Growth	30.00%	-158.25%	239.19%	-128.46%	-26.35%	-6.12%	-20.84%	299.58%	-143.19%	-71.95%
EPS Q/Q Growth	35.00%	-168.97%	231.82%	-128.57%	-23.00%	-5.66%	-16.54%	344.23%	-135.62%	-71.37%
Operating Cash Flow Q/Q Growth	-31.50%	419.69%	154.18%	-153.05%	13.62%	-31.22%	43.41%	-55.73%	19.79%	77.31%
Free Cash Flow Firm Q/Q Growth	133.13%	21.31%	-11.43%	-183.05%	-130.21%	-9.07%	363.19%	131.04%	45.29%	28.02%
Invested Capital Q/Q Growth	-4.87%	-4.00%	2.30%	4.31%	6.33%	-1.05%	0.02%	0.95%	-7.43%	-1.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	18.97%	17.93%	18.24%	17.56%	22.22%	20.00%	19.42%	18.79%	12.66%	17.56%
EBITDA Margin	2.78%	2.18%	3.48%	1.45%	5.67%	5.70%	5.44%	5.95%	0.67%	6.43%
Operating Margin	0.26%	0.47%	1.86%	0.06%	3.91%	4.52%	4.34%	4.98%	-2.13%	5.48%
EBIT Margin	0.53%	0.45%	2.01%	0.05%	3.87%	4.61%	4.32%	4.97%	-0.61%	5.49%
Profit (Net Income) Margin	-0.42%	-0.53%	0.84%	-0.60%	2.34%	2.83%	2.80%	3.38%	-1.85%	3.57%
Tax Burden Percent	87.50%	93.75%	77.44%	77.89%	77.61%	73.24%	75.65%	76.24%	68.59%	72.88%
Interest Burden Percent	-90.57%	-125.49%	54.07%	-1,583.33%	77.91%	83.83%	85.69%	89.13%	439.24%	89.26%
Effective Tax Rate	0.00%	0.00%	22.56%	0.00%	22.39%	26.76%	24.35%	23.76%	0.00%	27.12%
Return on Invested Capital (ROIC)	0.65%	1.22%	5.32%	0.17%	12.33%	13.78%	14.24%	18.59%	-8.01%	22.06%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.82%	-1.17%	3.61%	-1.81%	10.14%	12.21%	12.72%	17.22%	-9.02%	20.83%
Return on Net Nonoperating Assets (RNNOA)	-0.39%	-0.55%	1.77%	-0.82%	3.97%	5.15%	6.34%	9.29%	-5.73%	16.66%
Return on Equity (ROE)	0.26%	0.67%	7.09%	-0.64%	16.30%	18.93%	20.58%	27.88%	-13.74%	38.72%
Cash Return on Invested Capital (CROIC)	4.30%	-4.33%	-4.48%	-0.09%	7.66%	17.34%	19.52%	23.81%	29.37%	25.95%
Operating Return on Assets (OROA)	0.97%	0.86%	3.79%	0.09%	8.05%	9.79%	9.26%	12.01%	-1.65%	14.46%
Return on Assets (ROA)	-0.77%	-1.01%	1.59%	-1.15%	4.87%	6.01%	6.00%	8.16%	-4.97%	9.41%
Return on Common Equity (ROCE)	0.26%	0.66%	7.02%	-0.64%	16.15%	18.76%	20.40%	27.60%	-13.60%	38.28%
Return on Equity Simple (ROE_SIMPLE)	0.00%	2.75%	7.31%	10.30%	0.00%	10.94%	13.56%	31.52%	0.00%	58.96%
Net Operating Profit after Tax (NOPAT)	1.82	3.71	18	0.56	34	41	44	53	-19	62
NOPAT Margin	0.18%	0.33%	1.44%	0.05%	3.04%	3.31%	3.28%	3.80%	-1.49%	3.99%
Net Nonoperating Expense Percent (NNEP)	1.47%	2.39%	1.71%	1.98%	2.19%	1.58%	1.52%	1.37%	1.01%	1.23%
Return On Investment Capital (ROIC_SIMPLE)	0.14%	-	-	-	2.50%	-	-	-	-1.52%	-
Cost of Revenue to Revenue	81.03%	82.07%	81.76%	82.44%	77.78%	80.00%	80.58%	81.21%	87.34%	82.44%
SG&A Expenses to Revenue	18.71%	17.48%	16.24%	17.50%	18.31%	15.48%	15.08%	13.81%	14.79%	12.09%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.71%	17.46%	16.38%	17.50%	18.31%	15.48%	15.08%	13.81%	14.79%	12.09%
Earnings before Interest and Taxes (EBIT)	5.30	5.10	25	0.60	43	58	58	70	-7.90	85
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	28	25	43	18	63	71	73	84	8.60	99
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.72	0.79	0.76	1.28	1.27	1.10	1.76	1.49	1.20	1.03
Price to Tangible Book Value (P/TBV)	1.01	1.10	1.03	1.73	1.70	1.41	2.29	1.93	1.50	1.27
Price to Revenue (P/Rev)	0.13	0.14	0.14	0.23	0.22	0.18	0.27	0.22	0.17	0.14
Price to Earnings (P/E)	0.00	30.75	10.61	12.50	7.87	10.12	13.03	4.74	2.71	1.75
Dividend Yield	4.05%	3.75%	3.81%	2.21%	2.14%	2.46%	1.56%	1.72%	1.87%	1.86%
Earnings Yield	0.00%	3.25%	9.42%	8.00%	12.70%	9.88%	7.67%	21.08%	36.86%	57.01%
Enterprise Value to Invested Capital (EV/IC)	0.82	0.87	0.85	1.18	1.19	1.07	1.53	1.35	1.14	1.02
Enterprise Value to Revenue (EV/Rev)	0.23	0.25	0.24	0.32	0.30	0.25	0.34	0.28	0.22	0.21
Enterprise Value to EBITDA (EV/EBITDA)	9.16	7.79	6.03	7.09	5.28	6.07	7.75	3.64	2.19	1.50
Enterprise Value to EBIT (EV/EBIT)	29.12	15.76	9.34	10.04	6.73	8.36	10.27	4.19	2.42	1.61
Enterprise Value to NOPAT (EV/NOPAT)	47.02	21.53	12.67	13.40	8.92	10.79	13.35	5.34	3.22	2.38
Enterprise Value to Operating Cash Flow (EV/OCF)	5.06	5.70	7.96	6.75	4.21	2.86	3.56	3.33	2.78	3.16
Enterprise Value to Free Cash Flow (EV/FCFF)	18.83	0.00	0.00	0.00	15.96	5.94	7.50	5.71	4.04	4.37
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.57	0.62	0.59	0.55	0.48	0.41	0.46	0.45	0.41	0.53
Long-Term Debt to Equity	0.57	0.62	0.59	0.55	0.47	0.40	0.45	0.44	0.40	0.52
Financial Leverage	0.47	0.47	0.49	0.45	0.39	0.42	0.50	0.54	0.64	0.80
Leverage Ratio	2.88	2.87	2.92	2.88	2.71	2.79	3.03	3.12	3.27	3.78
Compound Leverage Factor	-2.61	-3.60	1.58	-45.60	2.11	2.34	2.60	2.78	14.36	3.37
Debt to Total Capital	36.18%	38.27%	37.21%	35.66%	32.31%	29.11%	31.37%	30.96%	29.13%	34.82%
Short-Term Debt to Total Capital	0.05%	0.13%	0.10%	0.27%	0.61%	0.47%	0.28%	0.31%	0.46%	0.70%
Long-Term Debt to Total Capital	36.13%	38.14%	37.12%	35.40%	31.70%	28.64%	31.10%	30.65%	28.67%	34.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.71%	0.67%	0.60%	0.62%	0.64%	0.66%	0.64%	0.63%	0.63%	0.55%
Common Equity to Total Capital	63.11%	61.06%	62.18%	63.71%	67.05%	70.23%	67.98%	68.41%	70.25%	64.62%
Debt to EBITDA	4.13	3.52	2.70	2.21	1.50	1.70	1.63	0.87	0.58	0.53
Net Debt to EBITDA	3.87	3.27	2.55	2.02	1.31	1.52	1.50	0.77	0.51	0.47
Long-Term Debt to EBITDA	4.12	3.51	2.69	2.19	1.47	1.67	1.61	0.86	0.57	0.52
Debt to NOPAT	21.20	9.73	5.67	4.17	2.53	3.02	2.81	1.27	0.85	0.84
Net Debt to NOPAT	19.87	9.04	5.36	3.81	2.21	2.71	2.59	1.13	0.75	0.75
Long-Term Debt to NOPAT	21.17	9.70	5.66	4.14	2.48	2.98	2.78	1.26	0.83	0.83
Altman Z-Score	2.87	2.87	2.94	2.95	3.25	3.44	3.61	3.92	3.98	3.89
Noncontrolling Interest Sharing Ratio	1.02%	1.00%	0.95%	0.94%	0.91%	0.89%	0.91%	0.98%	1.06%	1.12%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.08	2.22	2.38	2.09	2.18	2.14	2.03	2.19	2.33	2.41
Quick Ratio	0.78	0.91	0.96	0.81	0.82	0.92	0.86	0.99	0.89	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	35	-105	-134	-120	-42	140	154	33	-107	-196
Operating Cash Flow to CapEx	395.71%	431.41%	114.60%	-234.31%	360.40%	354.02%	249.57%	289.21%	535.69%	549.28%
Free Cash Flow to Firm to Interest Expense	3.45	-9.14	-11.82	-11.87	-4.46	15.07	18.57	4.38	-4.00	-21.53
Operating Cash Flow to Interest Expense	9.13	11.70	2.29	-4.73	9.48	8.53	13.89	10.58	6.78	16.66
Operating Cash Flow Less CapEx to Interest Expense	6.82	8.99	0.29	-6.75	6.85	6.12	8.33	6.92	5.51	13.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.84	1.89	1.89	1.93	2.08	2.12	2.14	2.42	2.69	2.63
Accounts Receivable Turnover	10.30	9.00	8.69	8.49	10.40	8.88	8.35	8.52	11.04	9.76
Inventory Turnover	5.13	5.53	5.19	5.11	5.17	5.33	5.23	6.22	6.15	5.70
Fixed Asset Turnover	7.50	7.98	8.50	9.14	9.75	10.87	11.88	13.51	14.94	16.55
Accounts Payable Turnover	8.33	8.27	7.80	7.20	9.06	8.79	7.62	8.57	10.90	9.07
Days Sales Outstanding (DSO)	35.45	40.53	41.98	42.98	35.08	41.12	43.72	42.84	33.05	37.38
Days Inventory Outstanding (DIO)	71.12	66.06	70.33	71.40	70.60	68.52	69.73	58.72	59.36	64.08
Days Payable Outstanding (DPO)	43.83	44.13	46.81	50.70	40.27	41.55	47.93	42.61	33.48	40.25
Cash Conversion Cycle (CCC)	62.74	62.47	65.50	63.68	65.41	68.10	65.53	58.95	58.93	61.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,263	1,327	1,383	1,352	1,296	1,219	1,231	1,231	1,220	1,317
Invested Capital Turnover	3.60	3.70	3.69	3.83	4.06	4.17	4.34	4.90	5.38	5.53
Increase / (Decrease) in Invested Capital	-33	109	151	120	76	-99	-110	20	88	258
Enterprise Value (EV)	1,037	1,155	1,174	1,598	1,537	1,305	1,884	1,661	1,395	1,347
Market Capitalization	589	661	670	1,135	1,147	970	1,510	1,303	1,061	915
Book Value per Share	$25.60	$25.09	$25.57	$25.88	$26.51	$25.67	$24.00	$23.60	$23.91	$23.88
Tangible Book Value per Share	$18.38	$18.12	$18.88	$19.12	$19.74	$19.95	$18.45	$18.21	$19.05	$19.40
Total Capital	1,292	1,364	1,412	1,395	1,351	1,257	1,263	1,276	1,260	1,370
Total Debt	467	522	525	497	437	366	396	395	367	477
Total Long-Term Debt	467	520	524	494	428	360	393	391	361	467
Net Debt	438	485	496	454	381	327	365	350	327	425
Capital Expenditures (CapEx)	23	31	23	20	25	22	46	28	34	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	599	681	778	757	702	692	708	750	788	954
Debt-free Net Working Capital (DFNWC)	628	718	808	800	758	731	739	795	828	1,006
Net Working Capital (NWC)	628	716	806	796	750	725	735	791	822	996
Net Nonoperating Expense (NNE)	6.02	9.71	7.36	7.96	7.76	5.93	6.51	5.87	4.62	6.49
Net Nonoperating Obligations (NNO)	438	485	496	454	381	327	365	350	327	425
Total Depreciation and Amortization (D&A)	23	20	18	17	20	14	15	14	17	15
Debt-free, Cash-free Net Working Capital to Revenue	13.02%	14.48%	16.13%	15.32%	13.75%	13.10%	12.68%	12.54%	12.46%	14.51%
Debt-free Net Working Capital to Revenue	13.66%	15.27%	16.74%	16.19%	14.83%	13.83%	13.24%	13.29%	13.10%	15.31%
Net Working Capital to Revenue	13.65%	15.23%	16.71%	16.11%	14.67%	13.72%	13.18%	13.23%	13.01%	15.16%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.13)	($0.20)	$0.29	($0.22)	$0.78	$1.02	$1.07	$1.30	($0.54)	$1.49
Adjusted Weighted Average Basic Shares Outstanding	31.85M	31.85M	33.20M	34.34M	34.02M	34.17M	34.39M	35.77M	36.99M	37.01M
Adjusted Diluted Earnings per Share	($0.13)	($0.20)	$0.29	($0.22)	$0.77	$1.00	$1.06	$1.27	($0.52)	$1.46
Adjusted Weighted Average Diluted Shares Outstanding	31.85M	31.85M	33.20M	34.34M	34.02M	34.17M	34.39M	35.77M	36.99M	37.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.85M	31.85M	33.20M	34.34M	34.02M	34.17M	34.39M	35.77M	36.99M	37.01M
Normalized Net Operating Profit after Tax (NOPAT)	1.82	3.57	19	0.56	34	41	44	53	-19	62
Normalized NOPAT Margin	0.18%	0.32%	1.55%	0.05%	3.04%	3.31%	3.28%	3.80%	-1.49%	3.99%
Pre Tax Income Margin	-0.48%	-0.57%	1.09%	-0.77%	3.01%	3.87%	3.70%	4.43%	-2.69%	4.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.52	0.44	2.18	0.06	4.53	6.18	6.99	9.20	-0.29	9.31
NOPAT to Interest Expense	0.18	0.32	1.56	0.06	3.55	4.43	5.31	7.02	-0.72	6.77
EBIT Less CapEx to Interest Expense	-1.78	-2.27	0.18	-1.96	1.89	3.77	1.42	5.54	-1.56	6.27
NOPAT Less CapEx to Interest Expense	-2.13	-2.39	-0.44	-1.96	0.92	2.03	-0.25	3.36	-1.98	3.73
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-339.73%	109.61%	39.56%	27.54%	16.94%	25.26%	20.27%	8.03%	5.08%	3.32%
Augmented Payout Ratio	-1,038.36%	359.83%	78.97%	94.97%	94.74%	137.58%	110.82%	45.35%	17.85%	12.90%

Frequently Asked Questions About Ryerson's Financials

When does Ryerson's financial year end?

According to the most recent income statement we have on file, Ryerson's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Ryerson's net income changed over the last 2 years?

Ryerson's net income appears to be on a downward trend, with a most recent value of -$7.30 million in 2024, falling from $391.50 million in 2022. The previous period was $146.40 million in 2023. Check out Ryerson's forecast to explore projected trends and price targets.

What is Ryerson's operating income?

Ryerson's total operating income in 2024 was $31.50 million, based on the following breakdown:

Total Gross Profit: $834.20 million
Total Operating Expenses: $802.70 million

How has Ryerson revenue changed over the last 2 years?

Over the last 2 years, Ryerson's total revenue changed from $6.32 billion in 2022 to $4.60 billion in 2024, a change of -27.3%.

How much debt does Ryerson have?

Ryerson's total liabilities were at $1.62 billion at the end of 2024, a 2.4% decrease from 2023, and a 12.1% increase since 2022.

How much cash does Ryerson have?

In the past 2 years, Ryerson's cash and equivalents has ranged from $27.70 million in 2024 to $54.30 million in 2023, and is currently $27.70 million as of their latest financial filing in 2024.

How has Ryerson's book value per share changed over the last 2 years?

Over the last 2 years, Ryerson's book value per share changed from 23.91 in 2022 to 25.60 in 2024, a change of 7.1%.

Related Companies

This page (NYSE:RYI) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ryerson (RYI) Financials

Frequently Asked Questions About Ryerson's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ryerson (RYI) Financials

Annual Income Statements for Ryerson

Quarterly Income Statements for Ryerson

Annual Cash Flow Statements for Ryerson

Quarterly Cash Flow Statements for Ryerson

Annual Balance Sheets for Ryerson

Quarterly Balance Sheets for Ryerson

Annual Metrics And Ratios for Ryerson

Quarterly Metrics And Ratios for Ryerson

Frequently Asked Questions About Ryerson's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools